OTTAWA – Parents and adolescents are concerned about the effects and potential harms of cannabis, and health care providers are increasingly expected to provide guidance and information about substance use with their young patients. New guidance from the Canadian Paediatric Society (CPS) gives them the tools to do so.
A 2019 survey showed that nearly half of Canadian adolescents between 16 and 19 years of age had used cannabis during the previous year. Since one in six youths who use cannabis will go on to misuse it, making timely, compassionate guidance a regular part of adolescent medicine is an important public health initiative.
“Cannabis is the most common substance for youth to seek substance abuse treatment for,” said Dr. Christina Grant, co-Chair of the CPS Cannabis Project Advisory Group. “By normalizing a conversation between adolescents and their health care providers, we hope to reduce the number of cases requiring that level of care.”
Recommendations for clinicians include:
“Respect for the patient is at the heart of this guidance,” said Dr. Grant, an adolescent medicine specialist at McMaster Children’s Hospital in Hamilton, Ontario. “We want teens to see their health care provider as a trusted source of information and a partner in their decision-making.”
Two clinical tools, including a visual guide to cannabis, and information for parents accompany the guidance document. All material can be accessed at www.cps.ca/en/cannabis.
This guidance is being published in a special issue of Paediatrics & Child Health, which will also include articles for primary care providers on cannabis and breastfeeding, edibles, and cannabis vaping. Funding for this project was provided by Health Canada.
-30-
The Canadian Paediatric Society is a national advocacy association that promotes the health needs of children and youth. Founded in 1922, the CPS represents more than 3,300 paediatricians, paediatric subspecialists and other child health professionals across Canada.
Last updated: Jun 4, 2020